Overall rank by patents
#30,732
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 14 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B21D (WORKING OR PROCESSING OF SHEET METAL OR METAL TUBES, RODS OR PROFILES WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL).
The verdict
Adval holds 8 US patents across 14 technology areas, rank #30,732 of 50,000 tracked assignees.
Adval TECH Holding Ag has been granted 8 US utility patents between 2018 and 2025, placing Adval TECH Holding Ag at rank #30,732 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 25.1 claims per patent with primary concentration in B21D (WORKING OR PROCESSING OF SHEET METAL OR METAL TUBES, RODS OR PROFILES WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL). As a Foreign Corporation, Adval TECH Holding Ag is one of the more focused assignees in the PatentsView dataset. By volume, Adval sits between Actinobac Biomed, Inc. (8 patents, rank #30,728) and Aegis Spine, Inc. (8 patents, rank #30,736) - the closest US assignees by grant volume. The composite Innovation Score of 55.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 2 in the 2015–2019 window, a +200% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Adval TECH Holding Ag's 25.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Adval TECH Holding Ag against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ACTINOBAC BIOMED, INC.
8 patents
AD-II ENGINEERING INC.
8 patents
ADEPTIO PHARMACEUTICALS LIMITED
8 patents
ADUCID S.R.O.
8 patents
ADVANCED DESIGN MFG LLC
8 patents
ADVANCED OSTEOTOMY TOOLS—AOT AG
8 patents
ADVANCED TRACK & TRACE
8 patents
AEGIS SPINE, INC.
8 patents
ADVAL TECH HOLDING AG
8 patents
What this shows Adval holds 8 patents at rank #30,732, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #30,732 in granted patent volume.
Other assignees with the most granted patents in Adval's primary technology class.
Adval's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
56 Top 7% higher than 93% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 25.0% |
| 2021 | 1 | 12.5% |
| 2022 | 3 | 37.5% |
| 2023 | 1 | 12.5% |
| 2025 | 1 | 12.5% |
Top 14 of 14 technology areas
Overall rank by patents
#30,732
Across all tracked assignees
55.8 out of 100
How to use this portfolio
Adval's 8 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.